Lucid Diagnostics Inc.

Historical 13F Holders

Symbol
LUCD
CUSIP
54948X109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 54948X109 since 12/18/2024, newest first.

Filer % of Class Filed
PAVmed Inc. 13D/A Amendment 6 27.5% 2/9/2026
Event 2/3/2026
PAVmed Inc. 13D/A Amendment 5 28.3% 10/10/2025
Event 10/9/2025
Ayrton Capital LLC 13G/A Amendment 2
2.0% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 9 6.11 M $4.59 M
2026 Q2 118 61.4 M $67.0 M
2026 Q1 104 35.6 M $41.0 M
2025 Q4 90 32.2 M $35.1 M
2025 Q3 88 35.2 M $35.6 M
2025 Q2 74 19.0 M $21.9 M
2025 Q1 50 9.39 M $14.1 M
2024 Q4 34 3.31 M $2.80 M
2024 Q3 31 2.45 M $2.00 M
2024 Q2 38 2.12 M $1.74 M
2024 Q1 34 2.07 M $1.69 M
2023 Q4 29 1.90 M $2.67 M
2023 Q3 25 1.92 M $2.24 M
2023 Q2 19 1.86 M $2.59 M
2023 Q1 20 1.77 M $2.49 M
2022 Q4 25 1.93 M $2.62 M
2022 Q3 25 2.34 M $3.58 M
2022 Q2 32 2.46 M $5.55 M
2022 Q1 33 2.71 M $9.09 M
2021 Q4 37 3.32 M $17.8 M